Taro Pharmaceuticals Canada Inc.'s Voluntary Recall of Docusate Sodium Capsules

Cronobacter (enterobacter) sakazakii is a bacteria that is a rare cause of serious or life-threatening infections, including meningitis and bloodstream infections, particularly in premature infants. Other vulnerable individuals include the elderly and those with weakened immune systems.

Contamination

Consumers should speak to their healthcare practitioner if they or any of their family members have used this product. Taro Pharmaceuticals Canada Inc. is advising consumers to discontinue use of Docusate Sodium Capsules USP, 100 mg" (Lot # 31040225). Report any adverse reaction potentially related to these products to Health Canada (see below). Media and consumers should contact Taro Pharmaceuticals Canada Inc. at 1-800-268-1975 for more information.